US2006189541A1PendingUtilityA1
Methods of treating dry eye disorders
Est. expirySep 20, 2022(expired)· nominal 20-yr term from priority
Inventors:Daniel A. Gamache
A61P 43/00A61K 31/416A61P 27/02A61K 31/616A61K 31/505A61K 31/506A61K 31/551A61K 31/192A61K 38/08
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Inhibitors of cytokine synthesis in nonimmune, resident ocular surface cells are useful for treating dry eye disorders and other disorders requiring the wetting of the eye.
Claims
exact text as granted — not AI-modified1 - 7 . (canceled)
8 . A method for the treatment of dry eye which comprises administering to a mammal a composition comprising a pharmaceutically acceptable carrier and a pharmaceutically effective amount of a c-jun N-terminal kinase inhibitor.
9 . The method of claim 8 wherein the pharmaceutically effective amount of the c-jun N-terminal kinase inhibitor is 0.001-1.0% (w/w).
10 . The method of claim 8 wherein the composition is topically administered to the eye.
11 . The method of claim 8 wherein the dry eye is associated with refractive surgery.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.